Bharat Biotech`s Covaxin effective against new COVID-19 variants, reveals study

In a recent development, a study conducted by Clinical Infectious Diseases in collaboration with National Institute of Virology and Indian Council of Medical Research (ICMR) has revealed that the 'made in India' COVID-19 vaccine, which is Bharat Biotech’s Covaxin, produces neutralising titres against all new key variants of COVID-19 including the double mutant strain B.1.617 and B.1.1.7.

from Zee News :India National https://ift.tt/3hqBUxO